The decision to scale back recommendations has raised concerns about insurance coverage and future access to COVID vaccines.

The move could alter guidance for doctors as well as some insurance coverage. Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

He is also demanding an inquiry into whether records were ... and other information relating to the COVID-19 pandemic and the vaccines must be thoroughly investigated.” Johnson and other ...

Previously, the FDA recommended COVID-19 vaccines for everyone aged 6 months and older. Under the new plan, shots for healthy kids and adults will need to go through placebo-controlled clinical trials before they can get approved.

The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical data is needed for healthy adults and kids.

The inquiry focused on vaccines and mandates; the lockdowns; and tools such as testing and tracing. The coalition government had also widened the scope of the inquiry to seek feedback on issues such as the social and economic impact of lockdowns.

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have risk factors for severe COVID-19.